Towa Pharmaceutical Co Ltd is a leading company in the pharmaceutical industry. They are committed to delivering high-quality healthcare products and services to improve the well-being of people's lives. Towa Pharmaceutical Co Ltd focuses on three core values: innovation, integrity, and excellence. Their corporate philosophy revolves around contributing to society through the development and manufacturing of innovative and safe pharmaceutical products. By prioritizing ethical business practices and maintaining strict quality standards, Towa Pharmaceutical Co Ltd is dedicated to creating value for their customers, stakeholders, and the healthcare industry as a whole.

Towa Pharmaceutical Co Ltd is primarily present in Japan.

Towa Pharmaceutical Co Ltd has achieved several significant milestones throughout its history. Notably, the company has gained recognition for its strong portfolio of generic drugs, contributing to the improvement of global healthcare accessibility. Towa Pharmaceutical Co Ltd has also expanded its market presence through strategic collaborations and acquisitions, further strengthening its position in the pharmaceutical industry. Additionally, the company has consistently prioritized research and development, resulting in innovative products that address diverse medical needs. Towa Pharmaceutical Co Ltd has successfully established itself as a reputable and trusted name in the pharmaceutical sector, driving sustainable growth and delivering value to its stakeholders.

Founded in 1943, Towa Pharmaceutical Co Ltd is a renowned pharmaceutical company based in Japan. With over a century of expertise in the industry, Towa Pharmaceutical specializes in the research, development, and production of high-quality generic and branded medications. The company has built a strong reputation for its commitment to innovation, safety, and efficacy in its products. Towa Pharmaceutical consistently strives to improve global healthcare by providing affordable and accessible medical solutions. With a diverse product portfolio and a focus on customer satisfaction, Towa Pharmaceutical continues to be a trusted name in the pharmaceutical sector.

The main competitors of Towa Pharmaceutical Co Ltd in the market include Daiichi Sankyo Co Ltd, Eisai Co Ltd, and Astellas Pharma Inc.

Towa Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

The business model of Towa Pharmaceutical Co Ltd revolves around the development, manufacture, and sale of pharmaceutical products. As a leading company in the healthcare sector, Towa Pharmaceutical focuses on researching and producing innovative drugs that cater to various therapeutic areas. With a strong emphasis on quality control and adherence to regulatory standards, Towa Pharmaceutical ensures the safety and effectiveness of its medicines. By continuously investing in research and development activities, the company aims to contribute to advancements in healthcare and provide patients with access to reliable treatment options. Towa Pharmaceutical Co Ltd is dedicated to improving global healthcare through its pharmaceutical business.

مُعامل القيمة السوقية إلى الأرباح لـ Towa Pharmaceutical Co هو ٨٫٩٨.

مُعامِل القيمة إلى المبيعات Towa Pharmaceutical Co هو ٠٫٦٤.

نقاط جودة AlleAktien لـ Towa Pharmaceutical Co هي 5/10.

Towa Pharmaceutical Co الإيرادات هي ٢٢٧٫٩٣ مليارات JPY.

صافي الربح Towa Pharmaceutical Co هو ١٦٫١٧ مليارات JPY.

Towa Pharmaceutical Co Ltd is a Japanese pharmaceutical company that focuses on the development, manufacturing, and marketing of medicines. The company is divided into several business segments, namely pharmaceutical products, OTC products, and medical devices. The pharmaceutical segment of the company focuses on the development and manufacturing of prescription drugs for a variety of diseases such as cardiovascular diseases, diabetes, neurological disorders, infections, and cancer. The company has an extensive portfolio of drugs available as single agents or in combinations. Some of Towa Pharmaceutical's most well-known drugs include thrombolytics, memotropil, and loxoprofen. The OTC segment specializes in over-the-counter medicines that are available in pharmacies and drugstores. The company offers a variety of products aimed at improving the well-being and health of consumers. These include pain relievers, cough and cold medicines, vitamins and minerals, and smoking cessation products. Towa Pharmaceutical's medical device segment produces a range of devices for the diagnosis and treatment of various diseases. These include devices for measuring blood sugar, blood pressure, and cholesterol, electronic inhalers, and products for hemodialysis. Towa Pharmaceutical Co Ltd aims to develop and manufacture highly effective and high-quality products to improve the well-being and health of people worldwide. To achieve this, the company continuously invests in research and development to develop innovative technologies and products. Through a consistent focus on the quality, safety, and effectiveness of its products, the company has gained a good reputation in the global market. Towa Pharmaceutical's products are distributed in more than 30 countries worldwide. In summary, Towa Pharmaceutical Co Ltd offers a wide range of pharmaceutical products, OTC products, and medical devices. The company aims to develop and manufacture highly effective and high-quality products to improve the well-being and health of people worldwide. Through its investments in research and development and its consistent focus on quality, safety, and effectiveness, Towa Pharmaceutical has gained a good reputation in the global market.

يوزع Towa Pharmaceutical Co أرباحًا قدرها ٦٣٫٠٠ JPY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Towa Pharmaceutical Co في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـTowa Pharmaceutical Co هو JP3623150004.

رمز WKN لـ Towa Pharmaceutical Co هو 891725.

الرمز المُختصر لـ Towa Pharmaceutical Co هو 4553.T.

خلال آخر 12 شهراً، دفعت Towa Pharmaceutical Co توزيعات أرباح بقيمة ٦٠٫٠٠ JPY . وهذا يعادل عائد توزيعات أرباح يقارب ٢٫٠٣ %. ومن المتوقع أن تدفع Towa Pharmaceutical Co خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٦٦٫٠٣ JPY.

نسبة توزيعات الأرباح الحالية لـ Towa Pharmaceutical Co هي ٢٫٠٣ %.

Towa Pharmaceutical Co يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أكتوبر, أبريل, أكتوبر, أبريل.

Towa Pharmaceutical Co دفعت توزيعات الأرباح كل عام خلال الـ23 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٦٦٫٠٣ JPY. وهذا يعادل عائد توزيعات أرباح قدره ٢٫٢٤ %.

Towa Pharmaceutical Co يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٣٠ JPY من Towa Pharmaceutical Co المُعلن عنها في ١‏/١٢‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٧‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ١‏/١٢‏/٢٠٢٤.

في العام 2023، وزعت Towa Pharmaceutical Co ٦٠ JPY كأرباح أسهم.

يتم توزيع أرباح Towa Pharmaceutical Co بالعملة JPY.